3918-84-1

Usage

Uses

Used in Pharmaceutical Industry:
H-GLU-ASP-OH is used as a pharmaceutical compound for its potential therapeutic applications. The dipeptide structure allows it to interact with various biological systems, making it a promising candidate for drug development and treatment of certain medical conditions.
Used in Cosmetic Industry:
In the cosmetic industry, H-GLU-ASP-OH is used as an ingredient in skincare products for its moisturizing and skin-protecting properties. The dipeptide can help improve skin hydration and maintain the skin's natural barrier function.
Used in Food Industry:
H-GLU-ASP-OH is used as an additive in the food industry to enhance flavor, texture, and shelf life. The dipeptide can act as a taste enhancer and improve the overall quality of various food products.
Used in Research and Development:
H-GLU-ASP-OH is used as a research tool in the field of biochemistry and molecular biology. The dipeptide can be utilized in the study of peptide synthesis, protein-protein interactions, and other biological processes.

InChI:InChI=1/C9H14N2O7/c10-4(1-2-6(12)13)8(16)11-5(9(17)18)3-7(14)15/h4-5H,1-3,10H2,(H,11,16)(H,12,13)(H,14,15)(H,17,18)

Upstream product

• 56-84-8 L-Aspartic acid 
• 56-86-0 L-glutamic acid 
• 100658-82-0 N-(N-benzyloxycarbonyl-L-α-glutamyl)-L-aspartic acid diethyl ester 
• 97707-08-9 N-(N-benzyloxycarbonyl-L-α-glutamyl)-L-aspartic acid 

Downstream Products

• 56-84-8 L-Aspartic acid 
• 56-86-0 L-glutamic acid 

Relevant academic research and scientific papers

Compositions and Methods for Binding Lysophosphatidic Acid

Compositions and methods for making and using anti-LPA agents, for example, monoclonal antibodies, are described.

Cell adhesion and extracellular matrix proteins

Various embodiments of the invention provide human cell adhesion and extracellular matrix proteins (CADECM) and polynucleotides which identify and encode CADECM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CADECM.

Green fluorescent protein fusions with random peptides

The invention relates to the use of fluorescent proteins, particularly green fluorescent protein (GFP), in fusion constructs with random and defined peptides and peptide libraries, to increase the cellular expression levels, decrease the cellular catabolism, increase the conformational stability relative to linear peptides, and to increase the steady state concentrations of the random peptides and random peptide library members expressed in cells for the purpose of detecting the presence of the peptides and screening random peptide libraries. N-terminal, C-terminal, dual N- and C-terminal and one or more internal fusions are all contemplated. Novel fusions utilizing self-binding peptides to create a conformationally stabilized fusion domain are also contemplated.

The Relationship between Taste and Primary Structure of "Delicious Peptide" (Lys-Gly-Asp-Glu-Glu-Ser-Leu-Ala) from Beef Soup

"Delicious peptide" was reported to be as delicious as beef soup.The peptide and its fragments were synthesized to study its taste active sites. "Delicious peptide" was found to produce a umami and a sour taste.By preparing several di- or tripeptides composed of basic or acidic amino acids, we found that the taste of "delicious peptide" was produced by an interaction between the basic and the acidic fragments in the peptide.